Form 4 for TENX TENAX THERAPEUTICS, INC.
Accepted 2026-07-14 19:29:41 ET · period of report 2026-07-13 · accession 0001193125-26-303600 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-07-14 19:29 | 2026-07-13 | TENX | Giordano Christopher Thomas | CEO, Dir | M - OptEx | $5.88 | +8,719 | 11.3K | +335% | +$51.3K |
| DM | 2026-07-14 19:29 | 2026-07-13 | TENX | Giordano Christopher Thomas | CEO, Dir | M - OptEx | $0.00 | -8,719 | 1.24M | -0.7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-13 | M | A | 219 | $3.55 | 2,824 | D | — | — | (F1) The aggregate exercise price was paid in cash. |
| 2 | Common | Common Stock | 2026-07-13 | M | A | 8,500 | $5.94 | 11,324 | D | — | — | (F1) The aggregate exercise price was paid in cash. |
| 3 | Derivative | Stock Option (right to buy) | 2026-07-13 | M | D | 219 | $0.00 | 218 | D | $3.55 · — to 2034-05-17 | 219 Common Stock | (F2) The options vest and become exercisable as follows: 25% of the underlying shares of common stock vest and become exercisable on each of May 17, 2025, May 17, 2026, May 17, 2027, and May 17, 2028, subject to the Reporting Person's continued employment. |
| 4 | Derivative | Stock Option (right to buy) | 2026-07-13 | M | D | 8,500 | $0.00 | 1,241,500 | D | $5.94 · 2025-12-10 to 2034-12-10 | 8,500 Common Stock |